Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 10, 2023
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
[ Thu, Aug 10th 2023
] - WOPRAI
Ami Fadia Reiterated (AVDL) at Strong Buy and Held Target at $18 on, Aug 10th, 2023
Ami Fadia of Needham, Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $18 on, Aug 10th, 2023.
Ami has made no other calls on AVDL in the last 4 months.
There are 3 other peers that have a rating on AVDL. Out of the 3 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ami
- Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $25 on, Friday, June 30th, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $16 on, Tuesday, May 2nd, 2023
- Patrick Dolezal of "LifeSci Capital" Maintained at Buy with Increased Target to $26 on, Tuesday, May 2nd, 2023
